DK0988300T3 - Benzo [5.6] cyclohepta [1.2-b] pyridine derivatives for inhibiton of farnesyl protein transferase - Google Patents

Benzo [5.6] cyclohepta [1.2-b] pyridine derivatives for inhibiton of farnesyl protein transferase

Info

Publication number
DK0988300T3
DK0988300T3 DK98928888T DK98928888T DK0988300T3 DK 0988300 T3 DK0988300 T3 DK 0988300T3 DK 98928888 T DK98928888 T DK 98928888T DK 98928888 T DK98928888 T DK 98928888T DK 0988300 T3 DK0988300 T3 DK 0988300T3
Authority
DK
Denmark
Prior art keywords
inhibiton
cyclohepta
benzo
protein transferase
pyridine derivatives
Prior art date
Application number
DK98928888T
Other languages
Danish (da)
Inventor
Ronald J Doll
Joseph M Kelly
Alan K Mallams
F George Njoroge
Stacy W Remiszewski
Arthur G Taveras
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DK0988300T3 publication Critical patent/DK0988300T3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98928888T 1997-06-17 1998-06-15 Benzo [5.6] cyclohepta [1.2-b] pyridine derivatives for inhibiton of farnesyl protein transferase DK0988300T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87705797A 1997-06-17 1997-06-17
PCT/US1998/011500 WO1998057959A1 (en) 1997-06-17 1998-06-15 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase

Publications (1)

Publication Number Publication Date
DK0988300T3 true DK0988300T3 (en) 2002-11-25

Family

ID=25369159

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98928888T DK0988300T3 (en) 1997-06-17 1998-06-15 Benzo [5.6] cyclohepta [1.2-b] pyridine derivatives for inhibiton of farnesyl protein transferase

Country Status (30)

Country Link
EP (2) EP0988300B1 (en)
JP (1) JP2002504148A (en)
KR (1) KR100588799B1 (en)
CN (1) CN1131228C (en)
AR (1) AR016074A1 (en)
AT (1) ATE222905T1 (en)
AU (1) AU753863B2 (en)
BR (1) BR9811470A (en)
CA (1) CA2294347C (en)
CO (1) CO4940455A1 (en)
CZ (1) CZ297450B6 (en)
DE (1) DE69807477T2 (en)
DK (1) DK0988300T3 (en)
ES (1) ES2178224T3 (en)
HK (1) HK1022908A1 (en)
HU (1) HUP0003046A3 (en)
ID (1) ID30349A (en)
IL (2) IL133449A0 (en)
MY (1) MY117925A (en)
NO (1) NO318938B1 (en)
NZ (1) NZ501618A (en)
PE (1) PE83799A1 (en)
PL (1) PL191866B1 (en)
PT (1) PT988300E (en)
RU (1) RU2220139C2 (en)
SK (1) SK283820B6 (en)
TR (2) TR200000114T2 (en)
TW (1) TW544451B (en)
WO (1) WO1998057959A1 (en)
ZA (1) ZA985210B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU229358B1 (en) 1998-07-06 2013-11-28 Janssen Pharmaceutica Nv Farnesyl protein transferase inhibitors for treating arthropathies
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
US6528523B2 (en) * 2000-11-29 2003-03-04 Schering Corporation Farnesyl protein transferase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
US4826853A (en) * 1986-10-31 1989-05-02 Schering Corporation 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Pharmaceutical compositions for inhibition of g-protein function and for treatment of proliferative diseases containing tricyclic compounds some such compounds and process for preparing part of them
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
CO4940455A1 (en) 2000-07-24
CA2294347A1 (en) 1998-12-23
PL191866B1 (en) 2006-07-31
RU2220139C2 (en) 2003-12-27
ZA985210B (en) 1999-01-07
PE83799A1 (en) 1999-10-23
MY117925A (en) 2004-08-30
IL133449A0 (en) 2001-04-30
AU753863B2 (en) 2002-10-31
PT988300E (en) 2002-12-31
EP0988300B1 (en) 2002-08-28
NO996236D0 (en) 1999-12-16
HUP0003046A2 (en) 2001-06-28
TW544451B (en) 2003-08-01
CN1131228C (en) 2003-12-17
IL133449A (en) 2006-12-10
AR016074A1 (en) 2001-06-20
JP2002504148A (en) 2002-02-05
PL337481A1 (en) 2000-08-28
ATE222905T1 (en) 2002-09-15
CZ297450B6 (en) 2006-12-13
EP0988300A1 (en) 2000-03-29
TR200000114T2 (en) 2000-08-21
KR100588799B1 (en) 2006-06-13
CZ447199A3 (en) 2000-06-14
BR9811470A (en) 2000-09-19
EP1156046A1 (en) 2001-11-21
HK1022908A1 (en) 2000-08-25
HUP0003046A3 (en) 2002-11-28
SK182499A3 (en) 2000-09-12
NO996236L (en) 2000-02-01
KR20010013948A (en) 2001-02-26
NO318938B1 (en) 2005-05-30
CN1267294A (en) 2000-09-20
ID30349A (en) 2001-11-22
WO1998057959A1 (en) 1998-12-23
DE69807477D1 (en) 2002-10-02
TR200003580T2 (en) 2002-10-21
ES2178224T3 (en) 2002-12-16
AU8058298A (en) 1999-01-04
SK283820B6 (en) 2004-02-03
CA2294347C (en) 2008-01-29
DE69807477T2 (en) 2003-02-27
NZ501618A (en) 2001-10-26

Similar Documents

Publication Publication Date Title
DK1019395T3 (en) Farnesyl transferase inhibitor 2-quinolone derivatives
FI974443A (en) Heterocyclic ring fused pyridine derivatives
DK0839136T3 (en) Benzo [g] quinoline derivatives
ATE302192T1 (en) TRICYCLIC PYROLEN OR PYRAZOLE DERIVATIVES
NO991560L (en) PDE IV inhibiting 2-cyanoiminoimidazole derivatives
PL337712A1 (en) Polymorphous form of 8-chloro-6, 11-dihydro-11-94-piperydilene) -5h-benzo[5,6]cyclohepta [1,2-b] pyridine
DE69825608D1 (en) BENZO [5,6] CYCLOHEPTAPYRIDINE DERIVATIVES APPLICABLE AS FARNESYL PROTEIN TRANSFERASE INHIBITORS
NO20005485D0 (en) Oral preparations containing 8-chloro-6,11-dihydro-11- (4-piperylidene) -5H-benzo- [5,6] cyclohepta [1,2-b] pyridine
DK0988300T3 (en) Benzo [5.6] cyclohepta [1.2-b] pyridine derivatives for inhibiton of farnesyl protein transferase
NO20012961D0 (en) Tricyclic farnesyl protein transferase inhibitors
DK1068194T3 (en) PDE IV inhibiting pyridine derivatives
DK0864564T3 (en) Particular method for the preparation of alpha-bromolactam derivatives
FI953170A0 (en) Oligunucleotides for inhibiting isoprenyl protein transferase expression
HUP0004806A3 (en) Benzo[5,6]cyclohepta[1,2-b]pyridine derivatives useful for inhibition of farnesyl protein transferase and medicaments containing the compounds
DK0912553T3 (en) Benzo [g] quinoline derivatives
HUP0002863A3 (en) Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase and pharmaceutical compositions containing them
DK0859770T3 (en) Process for the Synthesis of Benzo [b] Thiophenes